335 related articles for article (PubMed ID: 22108860)
1. Efficient reprogramming of human cord blood CD34+ cells into induced pluripotent stem cells with OCT4 and SOX2 alone.
Meng X; Neises A; Su RJ; Payne KJ; Ritter L; Gridley DS; Wang J; Sheng M; Lau KH; Baylink DJ; Zhang XB
Mol Ther; 2012 Feb; 20(2):408-16. PubMed ID: 22108860
[TBL] [Abstract][Full Text] [Related]
2. Residual expression of the reprogramming factors prevents differentiation of iPSC generated from human fibroblasts and cord blood CD34+ progenitors.
Ramos-Mejía V; Montes R; Bueno C; Ayllón V; Real PJ; Rodríguez R; Menendez P
PLoS One; 2012; 7(4):e35824. PubMed ID: 22545141
[TBL] [Abstract][Full Text] [Related]
3. Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34
Okumura T; Horie Y; Lai CY; Lin HT; Shoda H; Natsumoto B; Fujio K; Kumaki E; Okano T; Ono S; Tanita K; Morio T; Kanegane H; Hasegawa H; Mizoguchi F; Kawahata K; Kohsaka H; Moritake H; Nunoi H; Waki H; Tamaru SI; Sasako T; Yamauchi T; Kadowaki T; Tanaka H; Kitanaka S; Nishimura K; Ohtaka M; Nakanishi M; Otsu M
Stem Cell Res Ther; 2019 Jun; 10(1):185. PubMed ID: 31234949
[TBL] [Abstract][Full Text] [Related]
4. Rapid and Efficient Generation of Transgene-Free iPSC from a Small Volume of Cryopreserved Blood.
Zhou H; Martinez H; Sun B; Li A; Zimmer M; Katsanis N; Davis EE; Kurtzberg J; Lipnick S; Noggle S; Rao M; Chang S
Stem Cell Rev Rep; 2015 Aug; 11(4):652-65. PubMed ID: 25951995
[TBL] [Abstract][Full Text] [Related]
5. Enhanced human somatic cell reprogramming efficiency by fusion of the MYC transactivation domain and OCT4.
Wang L; Huang D; Huang C; Yin Y; Vali K; Zhang M; Tang Y
Stem Cell Res; 2017 Dec; 25():88-97. PubMed ID: 29125994
[TBL] [Abstract][Full Text] [Related]
6. Efficient Generation of Non-Integration and Feeder-Free Induced Pluripotent Stem Cells from Human Peripheral Blood Cells by Sendai Virus.
Ye H; Wang Q
Cell Physiol Biochem; 2018; 50(4):1318-1331. PubMed ID: 30355953
[TBL] [Abstract][Full Text] [Related]
7. Enhanced Generation of Integration-free iPSCs from Human Adult Peripheral Blood Mononuclear Cells with an Optimal Combination of Episomal Vectors.
Wen W; Zhang JP; Xu J; Su RJ; Neises A; Ji GZ; Yuan W; Cheng T; Zhang XB
Stem Cell Reports; 2016 Jun; 6(6):873-884. PubMed ID: 27161365
[TBL] [Abstract][Full Text] [Related]
8. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
[TBL] [Abstract][Full Text] [Related]
9. Generation of human induced pluripotent stem cells from cord blood cells.
Nishishita N; Takenaka C; Fusaki N; Kawamata S
J Stem Cells; 2011; 6(3):101-8. PubMed ID: 23264996
[TBL] [Abstract][Full Text] [Related]
10. Generation of Human iPSCs by Episomal Reprogramming of Skin Fibroblasts and Peripheral Blood Mononuclear Cells.
Febbraro F; Chen M; Denham M
Methods Mol Biol; 2021; 2239():135-151. PubMed ID: 33226617
[TBL] [Abstract][Full Text] [Related]
11. Efficient generation of integration-free ips cells from human adult peripheral blood using BCL-XL together with Yamanaka factors.
Su RJ; Baylink DJ; Neises A; Kiroyan JB; Meng X; Payne KJ; Tschudy-Seney B; Duan Y; Appleby N; Kearns-Jonker M; Gridley DS; Wang J; Lau KH; Zhang XB
PLoS One; 2013; 8(5):e64496. PubMed ID: 23704989
[TBL] [Abstract][Full Text] [Related]
12. A novel model of urinary tract differentiation, tissue regeneration, and disease: reprogramming human prostate and bladder cells into induced pluripotent stem cells.
Moad M; Pal D; Hepburn AC; Williamson SC; Wilson L; Lako M; Armstrong L; Hayward SW; Franco OE; Cates JM; Fordham SE; Przyborski S; Carr-Wilkinson J; Robson CN; Heer R
Eur Urol; 2013 Nov; 64(5):753-61. PubMed ID: 23582880
[TBL] [Abstract][Full Text] [Related]
13. Direct Reprogramming of Human Primordial Germ Cells into Induced Pluripotent Stem Cells: Efficient Generation of Genetically Engineered Germ Cells.
Bazley FA; Liu CF; Yuan X; Hao H; All AH; De Los Angeles A; Zambidis ET; Gearhart JD; Kerr CL
Stem Cells Dev; 2015 Nov; 24(22):2634-48. PubMed ID: 26154167
[TBL] [Abstract][Full Text] [Related]
14. Generation of transgene-free human induced pluripotent stem cells with an excisable single polycistronic vector.
Papapetrou EP; Sadelain M
Nat Protoc; 2011 Aug; 6(9):1251-73. PubMed ID: 21886095
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
[TBL] [Abstract][Full Text] [Related]
16. iPSCs-based generation of vascular cells: reprogramming approaches and applications.
Klein D
Cell Mol Life Sci; 2018 Apr; 75(8):1411-1433. PubMed ID: 29243171
[TBL] [Abstract][Full Text] [Related]
17. Zinc finger nuclease-expressing baculoviral vectors mediate targeted genome integration of reprogramming factor genes to facilitate the generation of human induced pluripotent stem cells.
Phang RZ; Tay FC; Goh SL; Lau CH; Zhu H; Tan WK; Liang Q; Chen C; Du S; Li Z; Tay JC; Wu C; Zeng J; Fan W; Toh HC; Wang S
Stem Cells Transl Med; 2013 Dec; 2(12):935-45. PubMed ID: 24167318
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional Reactivation of OTX2, RX1 and SIX3 during Reprogramming Contributes to the Generation of RPE Cells from Human iPSCs.
Li P; Sun X; Ma Z; Liu Y; Jin Y; Ge R; Hao L; Ma Y; Han S; Sun H; Zhang M; Li R; Li T; Shen L
Int J Biol Sci; 2016; 12(5):505-17. PubMed ID: 27019633
[TBL] [Abstract][Full Text] [Related]
19. OCT4 and SOX2 Work as Transcriptional Activators in Reprogramming Human Fibroblasts.
Narayan S; Bryant G; Shah S; Berrozpe G; Ptashne M
Cell Rep; 2017 Aug; 20(7):1585-1596. PubMed ID: 28813671
[TBL] [Abstract][Full Text] [Related]
20. Reprogramming human B cells into induced pluripotent stem cells and its enhancement by C/EBPα.
Bueno C; Sardina JL; Di Stefano B; Romero-Moya D; Muñoz-López A; Ariza L; Chillón MC; Balanzategui A; Castaño J; Herreros A; Fraga MF; Fernández A; Granada I; Quintana-Bustamante O; Segovia JC; Nishimura K; Ohtaka M; Nakanishi M; Graf T; Menendez P
Leukemia; 2016 Mar; 30(3):674-82. PubMed ID: 26500142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
